Image 1 caroussel

Program

Preliminary program

<<< Download >>>

 

Wednesday 21st November
14:00-16:00 The future of immunotherapy in oncology
16:00-17:00 Poster session (1)
17:00-19:00        
Resistance and signaling   Genome dynamics and cancer   Translational research, from biology to the clinic   Utilisation de bases de données médico-administratives   Health technologies
20:00-23:00 Speakers and moderators diner, under invitation

 

Thursday 22nd November
8:30-10:30 Plasticity   Réalité virtuelle et cancer
10:30-11:00 Break
11:00-12:30 Plasticity   Présentation de projets
12:30-13:30 Lunch
13:30-14:30 Poster session (2)
14:30-16:30 Hepatocellular carcinoma   Etude d'innovations en santé
16:30-17:00 Break
17:00-18:30 New publishing models
18:30-19:15 Artificial intelligence and cancer
20:00 Departure for Gala diner, social event

 

Friday 23rd November
8:30-10:15 Radiotherapy and DNA damage
10:15-10:45 Break
10:45-12:15 Microbiota and cancer
12:15-12:30 Poster session award - Closing ceremony
12:30-13:30 Lunch

 

 

Wednesday 21st November

14:00 - 16:00 : Plenary session

  • The future of immunotherapy in oncology
    • KEYNOTE SPEAKER: Aurélien MARABELLEGustave Roussy Institute (Paris)
    • Bruno SEGUI, Cancer Research Center of Toulouse (Toulouse) - TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
    • Nathalie BONNEFOY, Institute of Cancer Research of Montpellier (Montpellier) - Development of first-in-class humanized blocking antibody targeting CD39 ectonucleotidase for combined cancer immunotherapy
    • 3 selected talks

 

17:00 - 19:00 : Parallel sessions organized by Canceropole GSO Axis

  • Resistance and signaling / Axis 1 session
    • KEYNOTE SPEAKER: Eric SAHAIThe Francis Crick Institute (London) - Imaging therapy failure
    • Céline GONGORAInstitute of Cancer Research of Montpellier (Montpellier) - Inhibition of ATR overcomes resistance to oxaliplatin and promotes anti-tumour immunity in colorectal cancer
    • Olivier CALVAYRACCancer Research Center of Toulouse (Toulouse) - Targeting the early steps of adaptive resistance to EGFR tyrosine-kinase inhibitors in lung cancer
    • 3 selected talks

 

  • Genome dynamics and cancer / Axis 2 session
    • KEYNOTE SPEAKER: Jenny WUInstitute of Genetics and Development of Rennes (Rennes) - The organization of genome duplication is a critical determinant of the landscape of genome maintenance
    • Hervé SEITZ, Institute of Human Genetics (Montpellier) - Evaluation of the anti-proliferative role of the miR-34 miRNA in mammalian cells
    • 4 selected talks

 

  • Translational research, from biology to the clinic / Axis 3 session
    • 4 seected talks from Emergence Calls
    • 10 selected talks (flash posters)

 

  • Bases de données médico-administratives: utilisations en recherche en épidémiologie et sciences sociales / session Axe 4

 

  • Health technologies for Cancer / Axis 5 session
    • 10 selected talks for "Ma techno en 180 secondes" (flash posters toutes technologies)
    • KEYNOTE SPEAKERS "Nanohybrids for Cancer"
      • Joël CHOPINEAUCharles Gerhardt Institute (Montpellier) - Biological fate of silica based nanoparticles: physicochemistry and membranes interactions
      • Yannick GUARICharles Gerhardt Institute (Montpellier) - Nanosized Prussian blue analogues as theranostic agents
      • Hélène VAN DEN BERGHE, Max Mousseron Biomolecules Institute (Toulouse) - Biodegradable polymeric nanosystems for anti-cancer agent intracellular uptake

 

 

Thursday 22nd November

08:30 - 10:30 : Plenary session and session Axe 4

  • Plasticity

    • KEYNOTE SPEAKER: Manuel SERRANOInstitute for Research in Biomedicine (Barcelona) - An integrative view of cellular senescence and reprogramming
    • Jean-Emmanuel SARRY, Cancer Research Center of Toulouse (Toulouse) - Metabolic and mitochondrial flexibility in acute myeloid leukemia
    • Reini LUCO, Institute of Human Genetics (Montpellier) - Dynamic changes in chromatin regulate the highly dynamic changes in alternative splicing observed during the EMT
    • 2 selected talks

 

  • Réalité virtuelle et cancer 

 

11:00 - 12:30 : Plenary session and session Axe 4

  • Plasticity

    • KEYNOTE SPEAKER: Alain PUISIEUXCancer Research Center of Lyon (Lyon) - Cellular pliancy and breast cancer genetics
    • Jean-Philippe HUGNOT, Institute for Neurosciences of Montpellier (Montpellier) - Diversity and phenotypic plasticity of adult glioma cells
    • 2 selected talks

 

  • Projets financés au sein de l'axe 4 du Cancéropôle GSO
    • Virginie Woisard, Octogone-Lordat EA4156 (Toulouse) - Parolothèque
    • Pascal Ragouet, Centre Emile Durkheim UMR5116 (Bordeaux) - Des innovations biomédicales issues de l'aéronautique et du spatial ? Contribution à une analyse des processus translationnels en cancérologie
    • Laetitia Daubisse Marliac, registre des cancers du Tarn (Toulouse) - Règles d'enregistrement des tumeurs évolutives
    • Bruno Quintard, Bordeaux Population Health UMR1219 (Bordeaux) (sous réserve) - Le processus de décision lié à une reconstruction mammaire après mastectomie pour cancer: une approche psycho-anthropologique du couple

 

14:30 - 16:30 : Plenary session and session Axe 4 / Axe 5

  • Hepatocellular carcinoma

    • KEYNOTE SPEAKER: Jessica ZUCMAN-ROSSIFunctional Genetics of SOlid Tumors (Paris) - Genomics of liver tumors: new mechanisms of carcinogenesis
    • Eric ASSENAT, Departement of Medical Oncology, CHU de Montpellier and IGMM (Montpellier) - New landscape in HCC treatment : TKI and Immunotherapies 
    • Violaine MOREAU, Bordeaux Research in Translational Oncology (Bordeaux) - Role of Rnd3/RhoE in hepatocellular carcinoma progression
    • 2 selected talks

 

  • Etudes d'innovations en santé, en collaboration avec l'Axe 5 - Technologies pour la Santé

    • ORATEURS INVITES: Béatrice JACQUES et Philippe GORRY, Centre Emile Durkheim et Gretha, Bordeaux - l'exemple de l'étude de la radiologie interventionnelle
    • Table ronde: présentation d'innovations en développement au sein de l'axe 5.

 

17:00 - 18:30 : Plenary session

  • New publishing models

    • KEYNOTE SPEAKER: Andrea LEIBFRIEDLife Science Alliance (Germany) - Open Science & Publishing Models - how to share reproducible data
    • KEYNOTE SPEAKER: Yves GINGRASQuebec University (Canada)
    • GSO Speaker

 

18:30 - 19:15 : Plenary session

  • Artificial intelligence and cancer

    • KEYNOTE SPEAKER: Speaker to be announced

 

Friday 23rd November

2 plenary sessions

08:30 - 10:15 : Radiotherapy and DNA damage, in collaboration with SIRIC Montpellier Cancer 

    • KEYNOTE SPEAKER: Speaker to be announced

 

10:45 - 12:30: Microbiota and cancer

    • KEYNOTE SPEAKER: Joël DOREMicalis Institute "Food and Gut Microbiology for Human Health" (Jouy-en-Josas)
    • Nicolas CENAC, Digestive Health Research Institute (IRSD) (Toulouse) - Characterisation of bioactive lipid molecules produced by bacteria: role in intestinal homeostasis
    • INVITED SPEAKER: Mathias CHAMAILLARD, Lille infection and immunology centre, Institut Pasteur de Lille (Lille) - Remote control of antitumoral immunity by the gut microbiota
    • Philippe LEHOURS, Bordeaux Research in Translational Oncology (Bordeaux) - Impact of Helicobacter sp infection on gastric lymphomagenesis and microbiota